Titre : Thérapie socio-environnementale

Thérapie socio-environnementale : Questions médicales fréquentes

Termes MeSH sélectionnés :

Complement C3
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Thérapie socio-environnementale : Questions médicales les plus fréquentes", "headline": "Thérapie socio-environnementale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Thérapie socio-environnementale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-18", "dateModified": "2025-05-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Thérapie socio-environnementale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Psychothérapie", "url": "https://questionsmedicales.fr/mesh/D011613", "about": { "@type": "MedicalCondition", "name": "Psychothérapie", "code": { "@type": "MedicalCode", "code": "D011613", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Psychothérapie par le milieu", "alternateName": "Milieu Therapy", "url": "https://questionsmedicales.fr/mesh/D008884", "about": { "@type": "MedicalCondition", "name": "Psychothérapie par le milieu", "code": { "@type": "MedicalCode", "code": "D008884", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.864.392" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Communauté thérapeutique", "alternateName": "Therapeutic Community", "url": "https://questionsmedicales.fr/mesh/D013808", "about": { "@type": "MedicalCondition", "name": "Communauté thérapeutique", "code": { "@type": "MedicalCode", "code": "D013808", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.864.392.701" } } } ] }, { "@type": "MedicalWebPage", "name": "Psychothérapie de groupe", "alternateName": "Psychotherapy, Group", "url": "https://questionsmedicales.fr/mesh/D011615", "about": { "@type": "MedicalCondition", "name": "Psychothérapie de groupe", "code": { "@type": "MedicalCode", "code": "D011615", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.864.581" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Thérapie de couple", "alternateName": "Couples Therapy", "url": "https://questionsmedicales.fr/mesh/D019546", "about": { "@type": "MedicalCondition", "name": "Thérapie de couple", "code": { "@type": "MedicalCode", "code": "D019546", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.864.581.136" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Thérapie conjugale", "alternateName": "Marital Therapy", "url": "https://questionsmedicales.fr/mesh/D008388", "about": { "@type": "MedicalCondition", "name": "Thérapie conjugale", "code": { "@type": "MedicalCode", "code": "D008388", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.864.581.136.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Thérapie conjugale", "alternateName": "Marital Therapy", "url": "https://questionsmedicales.fr/mesh/D008388", "about": { "@type": "MedicalCondition", "name": "Thérapie conjugale", "code": { "@type": "MedicalCode", "code": "D008388", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.864.581.136.500" } } }, { "@type": "MedicalWebPage", "name": "Thérapie familiale", "alternateName": "Family Therapy", "url": "https://questionsmedicales.fr/mesh/D005196", "about": { "@type": "MedicalCondition", "name": "Thérapie familiale", "code": { "@type": "MedicalCode", "code": "D005196", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.864.581.273" } } }, { "@type": "MedicalWebPage", "name": "Psychodrame", "alternateName": "Psychodrama", "url": "https://questionsmedicales.fr/mesh/D011577", "about": { "@type": "MedicalCondition", "name": "Psychodrame", "code": { "@type": "MedicalCode", "code": "D011577", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.864.581.679" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Jeu de rôle", "alternateName": "Role Playing", "url": "https://questionsmedicales.fr/mesh/D012381", "about": { "@type": "MedicalCondition", "name": "Jeu de rôle", "code": { "@type": "MedicalCode", "code": "D012381", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.864.581.679.653" } } } ] }, { "@type": "MedicalWebPage", "name": "Jeu de rôle", "alternateName": "Role Playing", "url": "https://questionsmedicales.fr/mesh/D012381", "about": { "@type": "MedicalCondition", "name": "Jeu de rôle", "code": { "@type": "MedicalCode", "code": "D012381", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.864.581.679.653" } } }, { "@type": "MedicalWebPage", "name": "Groupes d'apprentissage en commun", "alternateName": "Sensitivity Training Groups", "url": "https://questionsmedicales.fr/mesh/D012681", "about": { "@type": "MedicalCondition", "name": "Groupes d'apprentissage en commun", "code": { "@type": "MedicalCode", "code": "D012681", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.864.581.813" } } } ] }, { "@type": "MedicalWebPage", "name": "Traitement résidentiel", "alternateName": "Residential Treatment", "url": "https://questionsmedicales.fr/mesh/D012114", "about": { "@type": "MedicalCondition", "name": "Traitement résidentiel", "code": { "@type": "MedicalCode", "code": "D012114", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.864.696" } } } ], "about": { "@type": "MedicalCondition", "name": "Thérapie socio-environnementale", "alternateName": "Socioenvironmental Therapy", "code": { "@type": "MedicalCode", "code": "D012960", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Terri A deRoon-Cassini", "url": "https://questionsmedicales.fr/author/Terri%20A%20deRoon-Cassini", "affiliation": { "@type": "Organization", "name": "Medical College of Wisconsin, USA." } }, { "@type": "Person", "name": "Guangrong Zheng", "url": "https://questionsmedicales.fr/author/Guangrong%20Zheng", "affiliation": { "@type": "Organization", "name": "College of Pharmacy, University of Florida, Gainesville, FL, USA." } }, { "@type": "Person", "name": "Vargas Del Río David", "url": "https://questionsmedicales.fr/author/Vargas%20Del%20R%C3%ADo%20David", "affiliation": { "@type": "Organization", "name": "Department of Habitat and Human Development. Periférico Sur Manuel Gómez Morín 8585, Instituto Tecnológico y de Estudios Superiores de Occidente, Santa María Tequepexpan, San Pedro Tlaquepaque, Jal 45604, Mexico." } }, { "@type": "Person", "name": "Brenner Ludger", "url": "https://questionsmedicales.fr/author/Brenner%20Ludger", "affiliation": { "@type": "Organization", "name": "Unidad Iztapalapa, Department of Sociology, Universidad Autónoma Metropolitana, Avenida San Rafael Atlixco 186, Mexico City 09340, Mexico." } }, { "@type": "Person", "name": "Natalia Hanazaki", "url": "https://questionsmedicales.fr/author/Natalia%20Hanazaki", "affiliation": { "@type": "Organization", "name": "Departamento de Ecologia E Zoologia, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Campus Universitário S/N, Florianópolis, SC, 88040-900, Brazil. natalia.hanazaki@ufsc.br." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Plasma complement C3 and C3a are increased in major depressive disorder independent of childhood trauma.", "datePublished": "2022-11-29", "url": "https://questionsmedicales.fr/article/36447174", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12888-022-04410-3" } }, { "@type": "ScholarlyArticle", "name": "Complement gene mutations in children with C3 glomerulopathy: do they affect the response to mycophenolate mofetil?", "datePublished": "2023-12-02", "url": "https://questionsmedicales.fr/article/38041748", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00467-023-06231-2" } }, { "@type": "ScholarlyArticle", "name": "Changes in serum TIM-3 and complement C3 expression in workers due to Mn exposure.", "datePublished": "2023-11-09", "url": "https://questionsmedicales.fr/article/38026392", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2023.1289838" } }, { "@type": "ScholarlyArticle", "name": "Complement C3 as a potential drug target in periodontitis: Evidence from the cis-Mendelian randomization approach.", "datePublished": "2023-11-05", "url": "https://questionsmedicales.fr/article/37926509", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jcpe.13894" } }, { "@type": "ScholarlyArticle", "name": "Microglia refine developing retinal astrocytic and vascular networks through the complement C3/C3aR axis.", "datePublished": "2023-03-01", "url": "https://questionsmedicales.fr/article/36762625", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1242/dev.201047" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Disciplines et activités comportementales", "item": "https://questionsmedicales.fr/mesh/D004191" }, { "@type": "ListItem", "position": 3, "name": "Psychothérapie", "item": "https://questionsmedicales.fr/mesh/D011613" }, { "@type": "ListItem", "position": 4, "name": "Thérapie socio-environnementale", "item": "https://questionsmedicales.fr/mesh/D012960" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Thérapie socio-environnementale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Thérapie socio-environnementale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Thérapie socio-environnementale", "description": "Comment évaluer l'impact de l'environnement sur la santé ?\nQuels outils sont utilisés pour le diagnostic ?\nQuels professionnels participent au diagnostic ?\nComment identifier les besoins socio-environnementaux ?\nQuelles échelles mesurent le bien-être social ?", "url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+C3&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Thérapie socio-environnementale", "description": "Quels symptômes indiquent un besoin de thérapie socio-environnementale ?\nComment l'environnement influence-t-il les symptômes ?\nQuels signes de détresse sociale sont observables ?\nLes symptômes varient-ils selon l'âge ?\nQuels symptômes physiques peuvent être liés à des facteurs sociaux ?", "url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+C3&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Thérapie socio-environnementale", "description": "Comment prévenir les problèmes socio-environnementaux ?\nQuels programmes de prévention existent ?\nQuel rôle joue la communauté dans la prévention ?\nComment évaluer l'efficacité des mesures préventives ?\nQuels facteurs de risque peuvent être ciblés ?", "url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+C3&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Thérapie socio-environnementale", "description": "Quels types de traitements sont offerts ?\nComment la thérapie de groupe aide-t-elle ?\nQuel rôle joue le counseling individuel ?\nComment les interventions communautaires sont-elles mises en œuvre ?\nQuels résultats attendus des traitements socio-environnementaux ?", "url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+C3&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Thérapie socio-environnementale", "description": "Quelles complications peuvent survenir sans traitement ?\nComment les complications affectent-elles la qualité de vie ?\nQuels impacts sur la santé physique peuvent être observés ?\nLes complications sont-elles réversibles ?\nComment prévenir les complications à long terme ?", "url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+C3&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Thérapie socio-environnementale", "description": "Quels facteurs de risque socio-environnementaux existent ?\nComment le stress environnemental influence-t-il la santé ?\nQuel rôle joue le soutien social dans la santé ?\nLes antécédents familiaux influencent-ils les risques ?\nComment l'accès aux ressources affecte-t-il la santé ?", "url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+C3&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'impact de l'environnement sur la santé ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation se fait par des questionnaires et des entretiens sur les conditions de vie." } }, { "@type": "Question", "name": "Quels outils sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des échelles de mesure et des outils d'évaluation psychosociale sont utilisés." } }, { "@type": "Question", "name": "Quels professionnels participent au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Psychologues, travailleurs sociaux et médecins collaborent pour le diagnostic." } }, { "@type": "Question", "name": "Comment identifier les besoins socio-environnementaux ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les besoins sont identifiés par des entretiens et des observations sur le terrain." } }, { "@type": "Question", "name": "Quelles échelles mesurent le bien-être social ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des échelles comme le SWLS (Satisfaction With Life Scale) sont utilisées." } }, { "@type": "Question", "name": "Quels symptômes indiquent un besoin de thérapie socio-environnementale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Symptômes de stress, d'anxiété, d'isolement social ou de dépression peuvent indiquer un besoin." } }, { "@type": "Question", "name": "Comment l'environnement influence-t-il les symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Un environnement stressant peut aggraver les symptômes psychologiques et physiques." } }, { "@type": "Question", "name": "Quels signes de détresse sociale sont observables ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Isolement, conflits familiaux et difficultés relationnelles sont des signes de détresse." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'âge et des expériences de vie." } }, { "@type": "Question", "name": "Quels symptômes physiques peuvent être liés à des facteurs sociaux ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, douleurs chroniques et troubles du sommeil peuvent être liés à des facteurs sociaux." } }, { "@type": "Question", "name": "Comment prévenir les problèmes socio-environnementaux ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par l'éducation, le soutien communautaire et l'amélioration des conditions de vie." } }, { "@type": "Question", "name": "Quels programmes de prévention existent ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des programmes de sensibilisation et des ateliers de compétences sociales sont disponibles." } }, { "@type": "Question", "name": "Quel rôle joue la communauté dans la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "La communauté peut offrir un soutien, des ressources et des activités pour renforcer les liens." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité des mesures préventives ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par des études de suivi et des retours d'expérience des participants." } }, { "@type": "Question", "name": "Quels facteurs de risque peuvent être ciblés ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs comme l'isolement social et le stress environnemental peuvent être ciblés." } }, { "@type": "Question", "name": "Quels types de traitements sont offerts ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie de groupe, le counseling et des interventions communautaires." } }, { "@type": "Question", "name": "Comment la thérapie de groupe aide-t-elle ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elle favorise le soutien social et l'échange d'expériences entre participants." } }, { "@type": "Question", "name": "Quel rôle joue le counseling individuel ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le counseling aide à identifier des stratégies personnelles pour faire face aux défis." } }, { "@type": "Question", "name": "Comment les interventions communautaires sont-elles mises en œuvre ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont mises en œuvre par des programmes de sensibilisation et des activités de groupe." } }, { "@type": "Question", "name": "Quels résultats attendus des traitements socio-environnementaux ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Amélioration du bien-être, réduction des symptômes et renforcement des liens sociaux." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir sans traitement ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Sans traitement, des complications comme la dépression chronique et l'isolement peuvent survenir." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent réduire la qualité de vie, affecter les relations et la santé physique." } }, { "@type": "Question", "name": "Quels impacts sur la santé physique peuvent être observés ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles cardiovasculaires et des problèmes immunitaires peuvent être exacerbés." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié et un soutien." } }, { "@type": "Question", "name": "Comment prévenir les complications à long terme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par un suivi régulier et des interventions précoces adaptées." } }, { "@type": "Question", "name": "Quels facteurs de risque socio-environnementaux existent ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Isolement social, pauvreté et conditions de vie précaires sont des facteurs de risque." } }, { "@type": "Question", "name": "Comment le stress environnemental influence-t-il la santé ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le stress environnemental peut aggraver les troubles mentaux et physiques." } }, { "@type": "Question", "name": "Quel rôle joue le soutien social dans la santé ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un bon soutien social réduit le risque de troubles mentaux et améliore le bien-être." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils les risques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de troubles mentaux augmentent le risque individuel." } }, { "@type": "Question", "name": "Comment l'accès aux ressources affecte-t-il la santé ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Un accès limité aux ressources augmente le risque de problèmes de santé physique et mentale." } } ] } ] }

Sources (1986 au total)

Plasma complement C3 and C3a are increased in major depressive disorder independent of childhood trauma.

Dysregulated complement system is linked to pathophysiology of major depressive disorder (MDD). Childhood trauma has been associated with an increased incidence of adult depression via a putative mech... The participants were 49 medication-free MDD patients and 45 healthy controls. All participants were asked to finish the Childhood Trauma Questionnaire, followed by blood sampling for measurement of p... Peripheral plasma concentration of C3 and C3a in medication-free MDD group was significantly higher than that in the healthy controls; whereas the concentration of plasma C1q and CRP in depressed pati... Our data suggest that complement C3 and C3a may be implicated in the pathophysiology of MDD, although traumatic childhood experiences were not associated with the circulating levels of complement C3, ...

Complement gene mutations in children with C3 glomerulopathy: do they affect the response to mycophenolate mofetil?

C3 glomerulopathy (C3G) is a complement-mediated disease. Although genetic studies are not required for diagnosis, they are valuable for treatment planning and prognosis prediction. The aim of this st... Sixty pediatric C3G patients were included, divided into two groups based on complement-related gene mutations. Demographic and clinical-pathological findings, treatment modalities, and outcome data w... Out of the 60 patients, 17 had mutations. The most common mutation was in the CFH gene (47%). The mean age at diagnosis was higher in the group with mutation (12.9 ± 3.6 vs. 11.2 ± 4.1 years, p = 0.03... This study is the largest pediatric C3G study examining the relationship between genotype and phenotype. We showed that the mutation group often presented with asymptomatic urinary abnormalities, was ...

Complement C3 as a potential drug target in periodontitis: Evidence from the cis-Mendelian randomization approach.

Evidence from a Phase IIa trial showed that a complement C3-targeted drug reduced gingival inflammation in patients with gingivitis. Using drug-target Mendelian randomization (MR), we investigated whe... We used multiple 'cis' instruments from the vicinity of the encoding loci of C3. Instrument selection was restricted to the drug target encoding loci (chromosome 19; 6,677,715-6,730,573 (GRCh37/hg19))... MR analysis revealed that the inhibition of C3 reduces the odds of periodontitis (OR 0.91 per 1 standard deviation reduction in C3; 95% confidence interval 0.87-0.96, p value = .0003).... Findings from our MR analysis suggest a potential protective effect of C3 blockade against periodontitis....

Serum C3 complement levels predict prognosis and monitor disease activity in Guillain-Barré syndrome.

Biomarkers are needed to predict prognosis and disease activity in patients with Guillain-Barré syndrome (GBS). The complement system is a key player in the pathogenesis of GBS. This study aimed to as... We reviewed the medical records of 76 GBS patients with C3 and C4 measurements during hospitalization between 2010 and 2021. Clinical outcomes were correlated with baseline serum C3, C4, and seven add... Higher C3, but not C4, was associated with poorer outcomes: lower Medical Research Council sum scores (MRCSS), higher GBS disability score (GBSDS), longer hospitalization, and more frequent treatment-... This study highlights the use of serum C3 as a novel mechanistic biomarker in GBS. Larger prospective studies are needed to validate our findings....

Relationship Between Serum Complement C3 Levels and Outcomes Among Patients With Anti-GBM Disease.

IgG and complement 3 (C3) are generally found to be deposited along the glomerular basement membrane (GBM) in human anti-GBM disease. The pathogenic role of complement activation in kidney damage of a... Ninety-four anti-GBM disease patients between January 2004 and December 2020 at the National Clinical Research Center of Kidney Diseases Jinling Hospital were retrospectively analyzed, and were divide... A total of 94 patients (aged 43.6 ± 16.2; male patients, 46%) with anti-GBM disease were enrolled. There were 26 patients with low C3 levels and 68 patients with normal C3 levels. Compared with the no... The kidney outcomes of anti-GBM disease in the low C3 group were poorer than those in the normal C3 group. The influence of C3 on the kidney outcomes of patients with anti-GBM disease may be of clinic...

Comparative analysis of complement C3 and C4 serum levels for outcome prediction in ANCA-associated renal vasculitis.

The activation of the complement system contributes essentially to the pathogenesis of anti-neutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis. We here aimed to directly compare levels... Serum levels of complement components C3 and C4 were directly compared in association with clinical and outcome data in a retrospective cohort of ANCA-associated renal vasculitis.... As compared to poor outcome prediction by low levels of complement C3 (p = 0.0093), low levels of complement C4 did not associate with early requirement of kidney replacement therapy (KRT) or death (p... While low levels of complement C3 were superior in predicting poor outcome in ANCA-associated renal vasculitis, a minor fraction with poor outcome had isolated C4 lowering not captured by serum C3 mea...

Implication of platelets and complement C3 as link between innate immunity and tubulointerstitial injury in renal vasculitis with MPO-ANCA seropositivity.

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a potentially life-threatening systemic small-vessel vasculitis that is characterized by pauci-immune glomerulonephritis, depi... A cohort of 53 biopsy-proven cases of ANCA-associated renal vasculitis were retrospectively enrolled in a single-center observational study. Univariate and multivariate regression analysis was perform... Lower platelet counts correlated with markers of kidney injury including eGFR loss (... Based on our observation that an association between platelets and complement system activation is only observed in the MPO-ANCA subgroup, this could implicate that platelets and complement C3 link in...